Bengaluru-based Strides Pharma to export Favipiravir antiviral drugs to treat COVID-19. The drug has proved to reduce the duration of COVID-19 & improve lung condition in patients. It is a generic version of Avigan of Toyoma Chemical, Japan, initially developed to treat influenza. Favipiravir tablets are being manufactured at Strides’ flagship facility in Bangalore. Strides is claimed to be the first Indian company to develop & commercially launch Firapiravar for the global market. The medicine is currently being exported to GCC countries.
